Overview

Safety and Efficacy of Daily Use of Micamlo® Combination Tablets AP in Patients With Hypertension

Status:
Completed
Trial end date:
2013-08-01
Target enrollment:
0
Participant gender:
All
Summary
Investigation of safety and efficacy of daily use of Micamlo Combination Tablets AP in patients with Hypertension
Accepts Healthy Volunteers?
No
Details
Lead Sponsor:
Boehringer Ingelheim
Criteria
Inclusion criteria:

- Male and Female patients with hypertension who did not receive of MICAMLO Combination
Tablets AP before the start of the study

Exclusion criteria:

- Patients with a history of hypersensitivity to any ingredient of Micamlo Combination
Tablets AP and dihydropyridine derivatives

- Pregnant woman or possibly pregnant woman

- Patients with extremely poor bile secretion or patients with serious hepatic disorder